Uncategorized
STAT+: Moderna launches early trial of Ebola mRNA vaccine
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. We’ve got a busy earnings week. Here’s the latest.
The need-to-know this morning
- Amgen and Gilead Sciences reported earnings last night.
- United Therapeutics reported earnings this morning.
Novo vs. Lilly
The two GLP-1 giants have both reported earnings.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. We’ve got a busy earnings week. Here’s the latest.
The need-to-know this morning
- Amgen and Gilead Sciences reported earnings last night.
- United Therapeutics reported earnings this morning.
Novo vs. Lilly
The two GLP-1 giants have both reported earnings.